TheStreet restated their buy rating on shares of Pfizer (NYSE:PFE) in a report released on Monday, StockRatingsNetwork.com reports. Pfizer Inc. (NYSE:PFE) stock opened at $30.58 in last session, and closed at $31.00, while the day range of stock is $30.55 – $31.05. The stock showed a positive weekly performance of 0.85%.
Merck & Co. Inc. (NYSE:MRK), the world’s third-biggest drugmaker is pulling back Liptruzet, a combination cholesterol drug, following concerns that the packaging may be defective that could hinder its effectiveness. Merck & Co., Inc. (NYSE:MRK) stock opened at $52.53, in last session and closed at $53.00, by losing -0.23%. The 52 week range of the stock is $40.83 – $53.44. Company’s market capitalization is $155.11 billion.
Teva Pharmaceutical Industries Ltd(ADR) (NYSE:TEVA) rose to a one-year high after the Israeli drugmaker said it plans to return to a deal-making strategy that made it one of the most acquisitive drug companies of the past decade. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock advanced 6.71% and finished the last session at $44.21. The EPS of the stock remained 1.41. Company’s market capitalization is $41.86 billion.
Galena Biopharma Biopharma Inc (NASDAQ:GALE) have signed a strategic partnership to develop and commercialize NeuVax (nelipepimut-S) in India. NeuVax is a vaccine aimed at preventing the recurrence of breast cancer in patients under remission. Galena Biopharma Inc (NASDAQ:GALE) stock opened the session at $7.76, and closed the session at $6.96. The 52 week range of the stock remained $1.65 – $7.77 and the day range was $6.85 – $7.77.